Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma.
作者： Jade Homsi , Christopher L. Cubitt , Shumin Zhang , Pamela N. Munster , Hua Yu
DOI: 10.1097/CMR.0B013E328304974C
关键词:
摘要: Src signaling has been implicated in several malignancies including melanoma. The prevalence of activation human melanoma and the effect newer inhibitors, dasatinib, bosutinib (SKI-606), as single agents or combination, on cell lines is not well established. In
elsevier.com
lww.com 
sci-hub.se 参考文章(35)
Heike Allgayer, Douglas D. Boyd, Markus M. Heiss, Eddie K. Abdalla, Steven A. Curley, Gary E. Gallick, Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis. Cancer. ,vol. 94, pp. 344- 351 ,(2002) , 10.1002/CNCR.10221
Rosalyn B. Irby, Weiguang Mao, Domenico Coppola, Jimmy Kang, Jean Marc Loubeau, Walter Trudeau, Richard Karl, Donald J. Fujita, Richard Jove, Timothy J. Yeatman, Activating SRC mutation in a subset of advanced human colon cancers Nature Genetics. ,vol. 21, pp. 187- 190 ,(1999) , 10.1038/5971
Kenneth H. Shain, William S. Dalton, Richard Jove, Mei Huang, Hua Yu, Rajani Ravi, Atul Bedi, Guilian Niu, Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest. Cancer Research. ,vol. 61, pp. 3276- 3280 ,(2001)
Yiqun G. Shellman, Young-Lip Park, David G. Marr, Katie Casper, Yisheng Xu, Mayumi Fujita, Robert Swerlick, David A. Norris, Release of Vascular Endothelial Growth Factor from a Human Melanoma Cell Line, WM35, Is Induced by Hypoxia but Not Ultraviolet Radiation and Is Potentiated by Activated Ras Mutation Journal of Investigative Dermatology. ,vol. 121, pp. 910- 917 ,(2003) , 10.1046/J.1523-1747.2003.12511.X
Rosalyn B Irby, Timothy J Yeatman, Role of Src expression and activation in human cancer Oncogene. ,vol. 19, pp. 5636- 5642 ,(2000) , 10.1038/SJ.ONC.1203912
Alireza Mirmohammadsadegh, Mohamad Hassan, Walter Bardenheuer, Alessandra Marini, Annett Gustrau, Sandeep Nambiar, Andrea Tannapfel, Hans Bojar, Thomas Ruzicka, Ulrich R. Hengge, STAT5 Phosphorylation in Malignant Melanoma Is Important for Survival and Is Mediated Through SRC and JAK1 Kinases Journal of Investigative Dermatology. ,vol. 126, pp. 2272- 2280 ,(2006) , 10.1038/SJ.JID.5700385
Sangkil Nam, Donghwa Kim, Jin Q. Cheng, Shumin Zhang, Ji-Hyun Lee, Ralf Buettner, Janni Mirosevich, Francis Y. Lee, Richard Jove, Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Cancer Research. ,vol. 65, pp. 9185- 9189 ,(2005) , 10.1158/0008-5472.CAN-05-1731
Guilian Niu, Tammy Bowman, Mei Huang, Steve Shivers, Douglas Reintgen, Adil Daud, Alfred Chang, Alan Kraker, Richard Jove, Hua Yu, Roles of activated Src and Stat3 signaling in melanoma tumor cell growth Oncogene. ,vol. 21, pp. 7001- 7010 ,(2002) , 10.1038/SJ.ONC.1205859
Renae L Malek, Rosalyn B Irby, Qingbin M Guo, Kerry Lee, Sylvia Wong, Mei He, Jennifer Tsai, Bryan Frank, Edison T Liu, John Quackenbush, Richard Jove, Timothy J Yeatman, Norman H Lee, Identification of Src transformation fingerprint in human colon cancer. Oncogene. ,vol. 21, pp. 7256- 7265 ,(2002) , 10.1038/SJ.ONC.1205900
Audrey C. Shor, Elizabeth A. Keschman, Francis Y. Lee, Carlos Muro-Cacho, G. Douglas Letson, Jonathan C. Trent, W. Jack Pledger, Richard Jove, Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival. Cancer Research. ,vol. 67, pp. 2800- 2808 ,(2007) , 10.1158/0008-5472.CAN-06-3469